Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clostridium difficile immune whey
- Development stage
- Discontinued
- Lead developer
- Novatreat
- Administration
- Oral
01
Overview
Clostridium difficile immune whey (CDIW) is a bovine-derived biologic developed by Novatreat Ltd for the treatment of recurrent Clostridioides (Clostridium) difficile infection (CDI) and associated diarrhea. It consists of a whey protein concentrate enriched with immunoglobulins, particularly secretory IgA (sIgA), derived from the colostrum and milk of cows immunized with an inactivated C. difficile vaccine containing toxins and whole cells. The product acts as a passive immunotherapy, where the bovine antibodies neutralize C. difficile Toxin A and Toxin B and inhibit bacterial colonization in the gastrointestinal tract. Development reached a Phase II randomized, double-blind trial in Finland comparing CDIW to metronidazole, but the study was terminated prematurely due to the bankruptcy of the developer, Novatreat Ltd.
- Other names
- Clostridium difficile-immune whey concentratebovine-derived Clostridium difficile immune whey
02
Targets
TcdA (Clostridioides difficile toxin A)TcdB (Clostridioides difficile large clostridial toxin family)
Beyond the preview
Go deeper on Clostridium difficile immune whey.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clostridium difficile immune whey.